Investors are always looking for stocks that are poised to beat at earnings season and Inozyme Pharma, Inc. INZY, may be one such company. The firm has earnings coming up pretty soon, and events are shaping up quite nicely for their report.
That is because Inozyme is seeing favorable earnings estimate revision activity as of late, which is generally a precursor to an earnings beat. After all, analysts raising estimates right before earnings — with the most up-to-date information possible — is a pretty good indicator of some favorable trends underneath the surface for INZY in this report.
In fact, the Most Accurate Estimate for the current quarter is currently at a loss of 46 cents per share for INZY, compared to a broader Zacks Consensus Estimate of a loss of 44 cents per share. This suggests that analysts have very recently bumped up their estimates for INZY, giving the stock a Zacks Earnings ESP of +12.11% heading into earnings season.
Inozyme Pharma, Inc. Price and EPS Surprise
Inozyme Pharma, Inc. price-eps-surprise | Inozyme Pharma, Inc. Quote
Why is this Important?
A positive reading for the Zacks Earnings ESP has proven to be very powerful in producing both positive surprises, and outperforming the market. Our recent 10-year backtest shows that stocks that have a positive Earnings ESP and a Zacks Rank #3 (Hold) or better show a positive surprise nearly 70% of the time, and have returned over 28% on average in annual returns (see more Top Earnings ESP stocks here).
Given that INZY has a Zacks Rank #3 and an ESP in positive territory, investors might want to consider this stock ahead of earnings. You can see the complete list of today’s Zacks #1(Strong Buy) Rank stocks here.
Clearly, recent earnings estimate revisions suggest that good things are ahead for Inozyme, and that a beat might be in the cards for the upcoming report.
Is THIS the Ultimate New Clean Energy Source? (4 Ways to Profit)
The world is increasingly focused on eliminating fossil fuels and ramping up use of renewable, clean energy sources. Hydrogen fuel cells, powered by the most abundant substance in the universe, could provide an unlimited amount of ultra-clean energy for multiple industries.
Our urgent special report reveals 4 hydrogen stocks primed for big gains - plus our other top clean energy stocks.
See Stocks NowInozyme Pharma, Inc. (INZY) : Free Stock Analysis Report
To read this article on Zacks.com click here.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
